| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 03/16/2004 | US6706881 Methods for preparing CETP inhibitors |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | WO2004020394A1 Novel composition containing acyl group |
| 03/11/2004 | WO2003106380A3 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/11/2004 | WO2003097587A3 Gelling agents |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040048895 Caspase-1 inhibitors and methods for their use |
| 03/11/2004 | US20040048857 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 03/11/2004 | US20040048835 7-Substituted fused ring tetracycline compounds |
| 03/11/2004 | US20040048834 Antitumoral compounds |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395546A1 Process for the production of high purity iohexol |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/09/2004 | US6703504 Conformationally constrained compounds as dendrimer cores |
| 03/09/2004 | US6703467 Adhesives and sealants |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/04/2004 | WO2004018644A2 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 03/04/2004 | WO2004018409A1 An improved process for the synthesis of (±) 2-amino-n-[2,(s,5-dimethoxyphenyl)-2-hydroxyethyl] acetamide monohydrochloride |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
| 03/04/2004 | WO2003045878A3 2,w-diaminocarboxylic acid compounds |
| 03/04/2004 | US20040044238 Reducing ketones using polydimethylsiloxane as reducing agents; froming alcohols; using complex catalyst |
| 03/04/2004 | US20040044075 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | DE10238114A1 Optisch aktive Diamine und deren Anwendung in katalytischen Prozessen Optically active diamines and their application in catalytic processes |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/03/2004 | EP1392279A1 Trimethyl lock based tetrapartate prodrugs |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | CN1479716A Propionic acid derivatives with PPAR-alpha activating properties |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CA2400996A1 1,4-substituted cyclohexane derivatives |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 02/26/2004 | WO2004016580A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 02/26/2004 | WO2004016213A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 02/26/2004 | WO2003104217A3 Prodrugs of excitatory amino acids |
| 02/26/2004 | WO2003097575A3 Amino-functional chalcones |
| 02/26/2004 | WO2003097574A3 Aminoalkoxy-functional chalcones |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | DE20215415U1 Wasserlösliche Medikamentenvorstufen von Propofol Water-soluble prodrugs of propofol |
| 02/26/2004 | CA2497347A1 R(+)-2-amino-3-hydroxypropanoic acid derivatives with glycinergic action |
| 02/26/2004 | CA2495588A1 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 02/25/2004 | EP1391457A1 Substituted 2-Phenylbenzimidazoles and their use as PARP inhibitors |
| 02/25/2004 | EP1391448A1 Optically active diamines and their use in catalytic processes |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1390357A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478074A Cyclohexyl (alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 02/25/2004 | CN1478068A Process for preparation of iopamidol and new intermediates therein |
| 02/25/2004 | CN1478063A Process for preparing of N.N'-substituted 5-amino-1,3-benzenedicarboxamides |
| 02/24/2004 | US6696606 Solid phase synthesis of arylretinamides |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | US6696424 Cytofectin dimers and methods of use thereof |
| 02/19/2004 | WO2004014973A2 Biodegradable polymer |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014350A2 Polymer conjugates of a local anaesthetic drug |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | WO2003024402A3 Lpa receptor agonists and antagonists and methods of use |
| 02/19/2004 | WO2002091989A3 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates |
| 02/19/2004 | WO2002032855A8 Mono- and polyamides of perfluoroalkyl-substituted unsaturated acids |
| 02/19/2004 | US20040034070 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/19/2004 | US20040033996 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1292572B1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/18/2004 | EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 02/18/2004 | EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 02/18/2004 | CN1138768C Method for preparation of citalopram |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/17/2004 | US6693208 Amino acids which deliver active agents to selected biological systems in increased or improved bioavailability |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 02/12/2004 | US20040028638 Carboxylic acid-type lipid |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |
| 02/11/2004 | EP0755385B1 Chelant compounds |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1137879C Process for preparing 3,-aminobenzoylamine |